Zura Bio (ZURA) stock was 69% lower pre-bell Monday after the company said a phase 2 clinical trial of tibulizumab in adults with moderate-to-severe hidradenitis suppurativa failed to meet its primary endpoint.
Orthofix Medical (OFIX) shares were down 24% after the company reported its Q3 results and revised its 2026 guidance.
Sable Offshore (SOC) stock was 22% lower after the company posted its Q3 financial results.
Digital Brands Group (DBGI) shares were down 22%, extending the nearly 40% fall in Friday's session.
The Children's Place's (PLCE) stock was 22% lower after the company said it voluntarily filed for Chapter 11 bankruptcy protection.
Comments